Whole-brain spectroscopic MRI biomarkers identify infiltrating margins in glioblastoma patients

BACKGROUND: The standard of care for glioblastoma (GBM) is maximal safe resection followed by radiation therapy with chemotherapy. Currently, contrast-enhanced MRI is used to define primary treatment volumes for surgery and radiation therapy. However, enhancement does not identify the tumor entirely...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neuro Oncol
Asıl Yazarlar: Cordova, James S., Shu, Hui-Kuo G., Liang, Zhongxing, Gurbani, Saumya S., Cooper, Lee A. D., Holder, Chad A., Olson, Jeffrey J., Kairdolf, Brad, Schreibmann, Eduard, Neill, Stewart G., Hadjipanayis, Constantinos G., Shim, Hyunsuk
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2016
Konular:
Neuroimaging
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4933486/
https://ncbi.nlm.nih.gov/pubmed/26984746
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/now036
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller